AstraZeneca Aktie
120,55
EUR
-4,45
EUR
-3,56
%
101,34
GBP
-3,70
GBP
-3,52
%
Werbung
AstraZeneca Aktie Analyse
| 11.05.18 | AstraZeneca overweight | Barclays Capital | |
| 24.04.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 24.04.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 24.04.18 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.04.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 18.04.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 13.04.18 | AstraZeneca buy | Jefferies & Company Inc. | |
| 13.04.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 09.04.18 | AstraZeneca buy | Deutsche Bank AG | |
| 19.03.18 | AstraZeneca buy | Jefferies & Company Inc. | |
| 14.03.18 | AstraZeneca buy | Société Générale Group S.A. (SG) | |
| 02.03.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.02.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 26.02.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 19.02.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 12.02.18 | AstraZeneca Hold | S&P Capital IQ | |
| 09.02.18 | AstraZeneca Hold | S&P Capital IQ | |
| 08.02.18 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.02.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 06.02.18 | AstraZeneca Neutral | UBS AG | |
| 06.02.18 | AstraZeneca buy | Deutsche Bank AG | |
| 06.02.18 | AstraZeneca buy | Kepler Cheuvreux | |
| 05.02.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 05.02.18 | AstraZeneca buy | Deutsche Bank AG | |
| 02.02.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.01.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 26.01.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 18.01.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 16.01.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 15.01.18 | AstraZeneca Neutral | UBS AG | |
| 11.01.18 | AstraZeneca buy | Deutsche Bank AG | |
| 08.01.18 | AstraZeneca Neutral | UBS AG | |
| 29.12.17 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 05.12.17 | AstraZeneca buy | Deutsche Bank AG | |
| 01.12.17 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 30.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 16.11.17 | AstraZeneca Reduce | HSBC | |
| 10.11.17 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 10.11.17 | AstraZeneca Hold | S&P Capital IQ | |
| 09.11.17 | AstraZeneca Neutral | UBS AG | |
| 08.11.17 | AstraZeneca buy | Citigroup Corp. | |
| 03.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 02.11.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 01.11.17 | AstraZeneca buy | Kepler Cheuvreux | |
| 01.11.17 | AstraZeneca buy | Deutsche Bank AG | |
| 01.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 01.11.17 | AstraZeneca Reduce | HSBC | |
| 23.10.17 | AstraZeneca Neutral | UBS AG | |
| 20.10.17 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 18.10.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
Werbung
Werbung